Used as a chiral building block in the synthesis of pharmaceuticals, particularly in the development of active pharmaceutical ingredients (APIs) requiring high enantiomeric purity. Its structure supports the creation of biologically active molecules, especially in drugs targeting central nervous system disorders and cardiovascular diseases. Commonly employed in asymmetric synthesis due to the presence of a stereogenic center, enabling selective reactions critical in drug design. Also utilized in the preparation of kinase inhibitors and other therapeutic agents where the (S)-enantiomer exhibits desired biological activity.